One of the most significant advantages of CAP is its ability to have a broad anti-microbial spectrum activity (including against MRSA bacteria) and biofilms, without the use of antibiotics. This is particularly important as antimicrobial resistance (AMR) is a major concern in both human and veterinary healthcare.
CAP has been shown to:
- Improve blood flow at the treatment site
- Help reduce infection in wounds
- Promote healing through increased cell proliferation
- Reduce inflammation by influencing the formation of cellular mediators
- Support the immune system
- Help promote muscle repair
Practical Clinical Advantages
Cold atmospheric plasma is applied externally and is well tolerated. For external wounds, it generally does not require sedation, saving time and resources while reducing procedural risk. This makes it suitable for a wide range of patients, including older or higher-risk animals.
CAP does not require protective clothing or eye protection, gels, or shaving of the treated area before application.
In Conclusion
CAP is a non-invasive, drug-free therapeutic option. The ionised gas generated at low temperatures is used for wound healing, for its antimicrobial effects and to support muscle repair.
Forte Healthcare has recently launched an innovative new veterinary device in the UK and Ireland featuring Cold Atmospheric Plasma (CAP) technology. The PetCellpen® is a novel handheld veterinary device that uses cold atmospheric plasma therapy to help treat wounds, skin conditions, infections, and musculoskeletal issues in animals. The therapeutic effects of cold plasma are mediated by, amongst other things, reactive oxygen and nitrogen species (RONS), which - when applied to the affected area - help support wound healing, reduce bacterial load, and help modulate inflammation without damaging tissue.
To learn more, explore PetCellpen®.